Detalhe da pesquisa
1.
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.
PLoS One
; 9(7): e101904, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25051027